GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » NonCurrent Deferred Liabilities

Australian Clinical Labs (ASX:ACL) NonCurrent Deferred Liabilities : A$0.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Australian Clinical Labs's non-current deferred liabilities for the quarter that ended in Dec. 2023 was A$0.0 Mil.

Australian Clinical Labs NonCurrent Deferred Liabilities Historical Data

The historical data trend for Australian Clinical Labs's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs NonCurrent Deferred Liabilities Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
NonCurrent Deferred Liabilities
1.50 - - -

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial - - - - -

Australian Clinical Labs NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Australian Clinical Labs (ASX:ACL) Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines